Immatics NV IMTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
10.77UNCH (UNCH)
Volume
7,070
Close
10.77quote price arrow down-0.12 (-1.10%)
Volume
243,345
52 week range
7.15 - 13.16
Loading...
  • Open11.08
  • Day High11.18
  • Day Low10.74
  • Prev Close10.89
  • 52 Week High13.16
  • 52 Week High Date03/01/24
  • 52 Week Low7.15
  • 52 Week Low Date10/31/23

Key Stats

  • Market Cap1.109B
  • Shares Out102.99M
  • 10 Day Average Volume0.35M
  • Dividend-
  • Dividend Yield-
  • Beta0.71
  • YTD % Change2.28

KEY STATS

  • Open11.08
  • Day High11.18
  • Day Low10.74
  • Prev Close10.89
  • 52 Week High13.16
  • 52 Week High Date03/01/24
  • 52 Week Low7.15
  • 52 Week Low Date10/31/23
  • Market Cap1.109B
  • Shares Out102.99M
  • 10 Day Average Volume0.35M
  • Dividend-
  • Dividend Yield-
  • Beta0.71
  • YTD % Change2.28

RATIOS/PROFITABILITY

  • EPS (TTM)-1.33
  • P/E (TTM)-8.12
  • Fwd P/E (NTM)-8.61
  • EBITDA (TTM)-101.343M
  • ROE (TTM)-44.26%
  • Revenue (TTM)57.912M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-179.63%
  • Debt To Equity (MRQ)6.84%

EVENTS

  • Earnings Date05/14/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Immatics NV

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Immatics NV is a clinical-stage biopharmaceutical company that is based in the Netherlands. The Company is focused on the discovery and development of T-Cell eceptors with the goal of enabling a robust and specific T-Cell response against these targets. The Company develops targeted immunotherapies with an emphasis on treating solid tumors through two distinct therapeutic modalities: Adoptive Cell Therapies (ACT) and antibody-like TCR Bispecifics (TCER). Its wholly owned...
Peter Chambre
Non-Executive Chairman of the Board
Harpreet Singh Ph.D.
Chief Executive Officer, Executive Director
Steffen Walter Ph.D.
Chief Operating Officer
Arnd Christ
Chief Financial Officer
Edward Sturchio
General Counsel
Address
Paul Ehrlich-Strasse 15
Tuebingen
72076
Germany

Top Peers

SYMBOLLASTCHG%CHG
MGNX
MacroGenics Inc
15.67+0.45+2.96%
RLAY
Relay Therapeutics Inc
7.04-0.04-0.56%
TNGX
Tango Therapeutics Inc
7.61+0.02+0.26%
SAGE
SAGE Therapeutics Inc
13.94+0.83+6.37%
IMNM
Immunome Inc
15.75+0.78+5.21%